← Open Payments lookup

JULIANNA KIRYLKA: Open Payments

NPI 1851085823 · WHITESBORO, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$296 in 15 payments from 9 companies in 2025. Trend: 2023 $19 · 2024 $145 · 2025 $296

Food & beverage: $296
CompanyPaymentsAmount
Novo Nordisk Inc3$54
GlaxoSmithKline, LLC.3$53
AstraZeneca Pharmaceuticals LP2$45
Lundbeck LLC2$38
Daiichi Sankyo Inc.1$26
Edwards Lifesciences Corporation1$25
Axsome Therapeutics, Inc.1$21
PFIZER INC.1$20
Lilly USA, LLC1$14

Products named: SHINGRIX, REXULTI, Ozempic, FARXIGA, INJECTAFER, Auvelity, ELIQUIS, Rybelsus.

Industry payments across NY — which companies pay providers there.